What is the first-line antibiotic regimen for acute appendicitis in an adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

First-Line Antibiotic Regimen for Acute Appendicitis in Adults

For non-critically ill adults with uncomplicated acute appendicitis, the first-line antibiotic regimen is amoxicillin/clavulanate 1.2–2.2 g every 6 hours OR ceftriaxone 2 g every 24 hours plus metronidazole 500 mg every 6 hours, administered initially intravenously with subsequent conversion to oral antibiotics based on clinical response. 1

Primary Antibiotic Options

The World Society of Emergency Surgery (WSES) 2020 Jerusalem Guidelines provide the following empiric regimens for community-acquired intra-abdominal infections in non-critically ill patients: 1

Standard regimens:

  • Amoxicillin/clavulanate 1.2–2.2 g every 6 hours 1
  • Ceftriaxone 2 g every 24 hours PLUS metronidazole 500 mg every 6 hours 1
  • Cefotaxime 2 g every 8 hours PLUS metronidazole 500 mg every 6 hours 1

Alternative Regimens for Special Circumstances

For beta-lactam allergy: 1

  • Ciprofloxacin 400 mg every 8 hours PLUS metronidazole 500 mg every 6 hours
  • Moxifloxacin 400 mg every 24 hours (monotherapy)

For patients at risk for ESBL-producing Enterobacteriaceae: 1

  • Ertapenem 1 g every 24 hours
  • Tigecycline 100 mg initial dose, then 50 mg every 12 hours

Evidence Supporting Carbapenem Superiority

A 2021 network meta-analysis found that carbapenems may offer superior outcomes compared to cephalosporins or beta-lactam/beta-lactamase inhibitor combinations, with surgery showing significantly better 1-year treatment success versus cephalosporins (OR: 16.79) or beta-lactam combinations (OR: 19.99), but not versus carbapenems (OR: 3.50). 2 Additionally, carbapenems were associated with fewer treatment-related complications compared with surgery (OR: 0.12). 2 This suggests that when choosing antibiotic therapy, carbapenems may be the optimal initial regimen, though the WSES guidelines still recommend beta-lactam combinations as first-line. 1

Route and Duration of Administration

Initial therapy: 1

  • Begin with intravenous antibiotics for a minimum of 48 hours
  • The APPAC trial used intravenous ertapenem for 3 days followed by oral levofloxacin (500 mg once daily) plus metronidazole (500 mg three times daily) for 7 days 3

Conversion to oral therapy: 1

  • Switch to oral antibiotics based on clinical improvement (resolution of fever, decreasing pain, tolerating oral intake)
  • Total antibiotic duration: 7–10 days 1

Clinical Context: When Antibiotics Are Appropriate

Antibiotics-first approach is reasonable for: 4, 5

  • Uncomplicated appendicitis (appendiceal diameter <13 mm on CT)
  • Absence of appendicolith on imaging
  • No mass effect or abscess formation
  • Patient preference after informed consent

Surgery should be prioritized when: 4, 5

  • Appendicolith present (associated with ~40% antibiotic failure rate)
  • Appendiceal diameter ≥13 mm
  • Mass effect on CT
  • Complicated appendicitis (perforation, abscess, peritonitis)

Important Caveats

Long-term recurrence rates: The 10-year APPAC follow-up demonstrated a 37.8% true appendicitis recurrence rate and 44.3% cumulative appendectomy rate in patients initially treated with antibiotics. 3 However, the overall complication rate remained significantly lower in the antibiotic group (8.5%) versus surgery (27.4%). 3

Population-based validation: A Swedish population-based study of 558 consecutive patients showed 77% recovery with antibiotics alone, with 11% experiencing recurrent appendicitis at 1-year follow-up. 6 This confirms that antibiotics work in unselected real-world populations, not just carefully selected trial participants.

Broad-spectrum coverage rationale: Piperacillin-tazobactam monotherapy or combination therapy with cephalosporins/fluoroquinolones plus metronidazole successfully treats uncomplicated acute appendicitis in approximately 70% of patients. 4 The need for anaerobic coverage (metronidazole) reflects the polymicrobial nature of appendiceal flora.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.